Obesity and demographic ageing are two global megatrends that overlap in a particularly unfavorable way in the cardiovascular system. Both factors independently increase the risk of cardiovascular disease, but also interact at common biological levels: from cellular senescence and mitochondrial dysfunction to structural cardiac and vascular remodeling. The state-of-the-art review by Ruperez et al. in the European Heart Journal sheds light on how obesity accelerates biological cardiovascular ageing, which mechanistic intersections can be found and which metabolic therapy strategies – from calorie restriction to GLP-1 receptor agonists and SGLT2 inhibitors – can modulate these processes.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Polypharmacy: use of eHealth tools in Switzerland
Survey study in primary care
- From symptom to diagnosis
Abdominal pain – Prostate abscess
- Asthma during pregnancy
Up to 40% suffer worsening of symptoms during pregnancy
- From symptom to diagnosis
Complicated renal cysts
- Atrial fibrillation
Anticoagulation after catheter ablation – for how long?
- Wound treatment and dermal defect coverage
Fish skin matrix for the treatment of complex ulcers
- Well-being of the medical profession in primary care
Findings of a nationwide survey in Switzerland
- Severe asthma and CRSwNP